Loctek Ergonomic Technology Corp.

What does Loctek Ergonomic Technology own?

Loctek owns the FlexiSpot consumer brand, its OEM linear drive and mounting hardware product lines, and a network of overseas warehouses operated as a logistics business for other exporters.

Is Loctek publicly traded?

Yes. Loctek has been listed on the Shenzhen Stock Exchange ChiNext board under ticker 300729 since December 1, 2017, the first ergonomic products company on a Chinese A-share exchange.

Who founded Loctek?

Xiang Lehong founded the company's predecessor in Ningbo in March 2002 and remains chairman and controlling shareholder.

Where is Loctek headquartered?

Loctek is headquartered at 436 Xueshi Road, Yinzhou District, Ningbo, Zhejiang Province, China.

What is Loctek's revenue?

Fiscal 2025 revenue was 6.71 billion yuan, approximately $940 million, up 18 percent year over year. Net income was 259 million yuan.

Who owns Loctek?

Chairman Xiang Lehong controls the company through founder-affiliated holding entities that together represent the largest block of shares, with public minority shareholders holding the rest through the Shenzhen listing.

The company's predecessor, Lijing Times, was established in March 2002 in Ningbo by Xiang Lehong, focused on electronic cables and mounting hardware for export markets. The business restructured into a joint stock company in 2010 under the Loctek name, formalizing the entity that would later list.

Through the 2000s and early 2010s Loctek was a classic Zhejiang exporter: it made monitor and TV mounting products that carried other companies' brand names, building manufacturing scale, quality certification labs, and relationships with Western retail channels without consumer recognition.

The strategic pivot came around 2015 to 2016 with the launch of Flexispot.com in the United States, the company's first independent consumer storefront. Rather than sell mounts to brands, Loctek would sell finished ergonomic furniture directly to Western consumers, capturing retail margin on top of manufacturing margin. The move coincided with rising awareness of sedentary-work health effects and the maturation of cross-border e-commerce infrastructure.

On December 1, 2017, Loctek listed on the Shenzhen Stock Exchange ChiNext growth board under ticker 300729, becoming the first ergonomic products manufacturer on a Chinese A-share exchange. IPO proceeds funded production expansion and the overseas warehouse buildout.

The pandemic transformed the company. Remote work demand drove revenue from 1.9 billion yuan in 2020 to 2.87 billion in 2021 and 3.9 billion in 2023 as home office furniture became essential purchases. FlexiSpot scaled from a niche DTC site into a recognized standing desk brand across Amazon US and Europe, earning a place on Kantar BrandZ's ranking of top Chinese global brands.

Revenue growth continued steeply: 5.67 billion yuan in fiscal 2024, up 45 percent, driven by both FlexiSpot sales and the rapidly growing overseas warehousing business that rents logistics capacity to other Chinese exporters. Net income that year came to 336 million yuan, down from 634 million in 2023 as logistics investment and competition pressured margins.

Fiscal 2025 produced 6.71 billion yuan in revenue, up 18 percent, with net income of 259 million yuan. Through 2025 and into 2026 the company has been navigating US tariff policy on Chinese goods, using its Vietnam production capacity and US warehouse network as mitigation, while continuing to expand FlexiSpot's product range and the logistics segment's warehouse footprint.

The FlexiSpot brand has been named to the Kantar BrandZ Top 50 Chinese Global Brand Builders ranking, the most cited independent measure of Chinese consumer brands' overseas presence. Loctek's production facilities operate Asia's first UL-witnessed laboratory for the category plus TUV and GS witnessed labs, credentials that matter for retail channel acceptance in Western markets.

No product safety scandal or major regulatory action is on record against Loctek or FlexiSpot. The company's public scrutiny centers on tariff exposure and the structural debate over Chinese cross-border e-commerce pricing rather than product or labor issues. Fiscal 2024's 47 percent net income decline despite 45 percent revenue growth drew analyst attention to margin quality, a standard financial scrutiny point rather than a controversy.